In 2015, the Joint Committee on Vaccination and Immunisation recommended ‘A HPV-MSM immunisation programme should be introduced for MSM up to and including the age of 45 years who attend GUM and HIV clinics, subject to procurement of the vaccine and delivery of the programme at a cost-effective price’. Public Health England invited some genitourinary medicine (GUM) clinics to take part in a pilot study to evaluate the acceptability and feasibility of human papillomavirus (HPV) vaccination (Gardasil) in individuals attending routine GUM appointments. Uptake of HPV vaccination is dependent on healthcare workers (HCWs) offering the vaccine.
We sent an anonymous electronic survey to all staff delivering HPV vaccination in June 2017, 7 months after the pilot started.
There were 41/104 (39%) responses from sexual health workers. Out of 40 respondents, 38 (95%) said that it was easy/very easy to discuss…